ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2018. The put-call ratio across all filers is 1.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,663,758 | -15.7% | 4,697,125 | -0.0% | 0.00% | – |
| Q2 2023 | $4,346,038 | -26.2% | 4,698,419 | -13.0% | 0.00% | -100.0% |
| Q1 2023 | $5,887,864 | -14.9% | 5,401,710 | +14.0% | 0.00% | 0.0% |
| Q4 2022 | $6,918,374 | +521.6% | 4,738,612 | +357.8% | 0.00% | – |
| Q3 2022 | $1,113,000 | -33.9% | 1,035,194 | +4.4% | 0.00% | – |
| Q2 2022 | $1,685,000 | +56.0% | 991,444 | +89.1% | 0.00% | – |
| Q1 2022 | $1,080,000 | -46.5% | 524,212 | -2.6% | 0.00% | – |
| Q4 2021 | $2,018,000 | -46.7% | 538,111 | -26.5% | 0.00% | – |
| Q3 2021 | $3,785,000 | +6781.8% | 732,095 | +5537.1% | 0.00% | – |
| Q2 2021 | $55,000 | -97.1% | 12,987 | -96.3% | 0.00% | – |
| Q1 2021 | $1,886,000 | +14407.7% | 355,054 | +15021.6% | 0.00% | – |
| Q4 2020 | $13,000 | 0.0% | 2,348 | +49.7% | 0.00% | – |
| Q3 2020 | $13,000 | -40.9% | 1,568 | -28.4% | 0.00% | – |
| Q2 2020 | $22,000 | +266.7% | 2,190 | -5.0% | 0.00% | – |
| Q1 2020 | $6,000 | 0.0% | 2,305 | -55.9% | 0.00% | – |
| Q4 2019 | $6,000 | -76.9% | 5,222 | -22.1% | 0.00% | – |
| Q2 2019 | $26,000 | +2500.0% | 6,700 | +2409.4% | 0.00% | – |
| Q1 2019 | $1,000 | -83.3% | 267 | -77.1% | 0.00% | – |
| Q4 2018 | $6,000 | 0.0% | 1,168 | +150.1% | 0.00% | – |
| Q3 2018 | $6,000 | -87.0% | 467 | -88.0% | 0.00% | – |
| Q2 2018 | $46,000 | -30.3% | 3,906 | -33.5% | 0.00% | – |
| Q1 2018 | $66,000 | -22.4% | 5,871 | -53.6% | 0.00% | – |
| Q4 2017 | $85,000 | +1316.7% | 12,655 | +1614.8% | 0.00% | – |
| Q3 2017 | $6,000 | +500.0% | 738 | +450.7% | 0.00% | – |
| Q2 2017 | $1,000 | -99.2% | 134 | -99.2% | 0.00% | – |
| Q2 2016 | $131,000 | +4266.7% | 16,093 | +4458.9% | 0.00% | – |
| Q1 2016 | $3,000 | -25.0% | 353 | +76.5% | 0.00% | – |
| Q2 2015 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |